You’re Probably Undercharging by 30%. Here’s How to Know for Sure.

If patients never push back on your pricing, you win every consult against premium competitors, or your margins are shrinking while revenue grows, you are almost certainly undercharging. Research across cash-pay healthcare shows that a 1% improvement in price realization has 2-4x the profit impact of a 1% improvement in volume — yet most practice owners set their rates once and never meaningfully revisit them. A 90-minute pricing audit that scores outcome clarity, proof strength, and competitive position will tell you exactly how large the gap is.

At a glance

Most common gap: Practices set injectable and membership pricing early, when they had the least information, and never adjust upward as reputation and results improve.
Real-world elasticity: A 10-20% price increase in cash-pay aesthetics typically results in only 1-3% patient loss — not the mass exodus owners fear.
Profit leverage: Price is the single highest-leverage variable in your practice, yet it is the one most owners touch least.
Where to start: Score your offer on outcome clarity, proof strength, and competitive position. If you score high and prices haven’t moved in two years, the gap is probably larger than you think.

Key takeaways

A 1% price improvement has 2-4x the profit impact of a 1% volume improvement. Price is your highest-leverage variable, and it is probably the one you have touched least recently.
Most cash-pay patients are far less price-sensitive than you assume. Switching costs are real. A 10-20% increase typically results in 1-3% patient loss — and the math almost always favors the increase.
Price on the outcome, not your costs. If your GLP-1 program helps a patient lose 30 pounds and reclaim their confidence, charging $500/month is a fraction of that transformation’s value — and your cost of the medication is irrelevant to that equation.
Start with a 90-minute audit: score your offer on outcome clarity, proof strength, and competitive position. If you score low on all three, fix those before raising prices. If you score high and your prices haven’t moved in two years — the gap is probably larger than you think.
See where pricing fits in your full revenue picture. Take the free diagnostic →

When I was building the pricing dimension of the AI diagnostic, I needed to understand what separates practices that capture full value from those that leave money on the table. I went deep into pricing research — behavioral economics, willingness-to-pay studies, aesthetics industry pricing data, and decades of direct-response pricing strategy.

The pattern that emerged was stark: most cash-pay practices set their per-unit injectable rates and membership pricing once, early, when they had the least information — and never meaningfully revisit them.

Meanwhile, their costs rise, their technique improves, their reputation strengthens, and their patients would pay more. But nobody asks.

When was the last time you actually raised your prices?

For most practice owners, the honest answer is “more than a year ago” — often two or three years. The research explains why: pricing feels dangerous. It triggers a fear response that’s out of proportion to the actual risk.

The data tells a different story. Studies across industries consistently show that a 1% improvement in price realization has 2-4x the profit impact of a 1% improvement in volume. Price is the single highest-leverage variable in your practice — and it’s the one most owners touch least.

Three signals suggest you’re undercharging:

Patients never question your pricing. If your consultation-to-booking rate is above 80%, you’re probably not priced at your value ceiling. Some pushback is healthy — it means you’re in the right range. Zero pushback means you’re leaving a gap between what you charge and what the market would bear. You’ve built 200+ five-star Google reviews and 15K Instagram followers — your pricing should reflect that positioning, not where you started.

Patients choose you over premium competitors. Winning every consult sounds good until you realize what it means: you’re the cheap option. The research on competitive pricing shows that practices positioned on price attract the most price-sensitive patients — who are also the most likely to chase discounts, skip follow-up appointments, and shop around for every treatment.

Your margins are shrinking while revenue grows. Revenue up, profit flat (or down) is the classic sign of a pricing structure that hasn’t kept pace with cost increases. A practice doing $1M with 20% margins and a practice doing $1.5M with 10% margins net the same dollars — but the second one is working 50% harder for it.

What does a 15% price increase actually look like?

Let’s run the math for an aesthetics practice doing $600,000 annually.

A 15% price increase moves revenue to $690,000 — an additional $90,000 per year. If you lose 5% of your patients over the adjustment (a typical worst case in the research), you’re still up $60,000 while serving fewer patients with less operational strain.

The research on price elasticity in cash-pay healthcare is encouraging for practice owners: most cash-pay patients are far less price-sensitive than providers assume. Aesthetics industry pricing data shows that practices raising rates 10-20% saw patient loss rates of 1-3% — not the mass exodus that owners fear.

The reason is simple: switching costs are real. Your patients would need to find a new injector, build trust from scratch, risk inconsistent results, and accept the transition uncertainty — all to save 15%. Most won’t.

Why do practices underprice so consistently?

The research points to three structural causes, not character flaws:

Cost-based thinking. Most owners price by calculating their cost of goods and adding a margin. This ignores the most important variable: what is the outcome worth to the patient? An injector whose time is worth $400/hr but who charges for units at commodity rates is selling product, not transformation. If a patient’s Botox treatment gives her three months of confidence in client-facing meetings, the outcome is worth far more than the per-unit cost of the toxin.

Anchoring to launch prices. The Botox per-unit rate and membership fee you set when you had thirty patients and no reputation becomes an anchor that’s hard to move. But your value proposition at year five — with hundreds of five-star reviews, a refined technique, and a loyal patient base — is fundamentally different from year one. Your pricing should reflect that.

Comparison to the wrong competitors. Practices often price against the cheapest alternative rather than the most comparable one. A master injector competing on price with a new practitioner at a chain med spa is playing the wrong game. The relevant comparison is what a board-certified dermatologist or plastic surgeon charges for the same treatment — and suddenly your rate looks like a bargain.

How do you know what your price should actually be?

The pricing research I studied points to a structured approach rather than guesswork:

Score your offer on outcome clarity. Can you articulate the specific, measurable result your patient gets? “We do injectables” is worth less than “Our patients see an average 40% reduction in fine lines within two weeks, with results lasting 3-4 months.” The more specific the outcome, the more defensible the price.

Score your offer on proof strength. Do you have before-and-after galleries, patient testimonials, or outcome data showing results? Every piece of proof reduces the patient’s perceived risk — and perceived risk is the main thing suppressing your price. Practices with strong proof portfolios consistently command 20-40% premiums over those without.

Score your competitive position. Are you genuinely differentiated, or are you one of 50 practices offering the same menu at similar rates? Differentiation enables pricing power. If you can’t articulate why a patient should choose you at a higher price — whether it’s your injection technique, your clinical results, or your membership experience — the market will force you to compete on the lower one.

Test before you commit. The smartest approach from the research: raise prices for new patients first. Existing patients keep their current rate for 90 days, then move to the new structure. This gives you real market data on elasticity before making a wholesale change.

What about the patients who leave?

Some will. The research suggests 1-5% for a moderate increase (10-20%), and that’s actually healthy.

The patients most sensitive to a price increase are typically the ones who generate the most support load, negotiate the hardest on every treatment, and have the lowest lifetime value. They’re the ones who only book during flash sales and never refer. Losing them often improves both margins and morale.

One pricing study I found particularly striking: practices that raised prices and lost their bottom 10% of patients by revenue saw net profit increase by 15-25% — because the operational savings from not serving difficult, low-margin accounts exceeded the lost revenue.

This is why pricing became one of the highest-weighted factors in the Revenue dimension of the diagnostic. It’s the lever most practices have never pulled — and the one with the most immediate impact.

FAQ

How do I know if my med spa is undercharging? Three signals point to underpricing: patients never push back on your rates, you consistently win consults against premium competitors, and your margins are shrinking even as revenue grows. If all three are true, a pricing gap is almost certain.

How much can a med spa raise prices before losing patients? Aesthetics industry pricing data shows that practices raising rates 10-20% typically see patient loss rates of only 1-3%. Switching costs — finding a new injector, rebuilding trust, risking inconsistent results — keep most patients in place even after a moderate increase.

Should I raise prices for existing patients or just new ones? The lowest-risk approach is to raise prices for new patients first, then transition existing patients to the new structure after 90 days. This gives you real market data on how the new pricing performs before applying it across the board.

What is the profit impact of a price increase vs. adding more patients? Research across industries consistently shows that a 1% improvement in price realization delivers 2-4x the profit impact of a 1% improvement in patient volume. Price is the highest-leverage variable in a cash-pay practice because every dollar of increase flows almost entirely to the bottom line.

How do I set the right price for injectable treatments? Score your offer on three factors: outcome clarity (can you articulate the specific result?), proof strength (do you have before-and-afters, testimonials, and outcome data?), and competitive position (are you differentiated from commodity providers?). High scores on all three support premium pricing; low scores mean you should strengthen your positioning before raising rates.

Written by Bill Eisenhauer, Founder of Alchemy Inside. Bill works with cash-pay practice owners to find the revenue, margin, and capacity already inside their operations — using diagnostics, not guesswork.

Take the free diagnostic →

You're Probably Undercharging by 30%. Here's How to Know for Sure.